Autologous Stem Cell Transplantation for Crohn's Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Autologous Stem Cell Transplantation for Crohn's Disease — Stella

Home/Crohn's Disease/

View on ClinicalTrials.gov

Recruiting

Back to Crohn's Disease trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

UPMC Prebyterian- Adult Gastroenterology, Pittsburgh, Pennsylvania

Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team, Pittsburgh, Pennsylvania

Key details

Phase

Early testing / Safety & dosing

Sponsor

Paul Szabolcs

Enrollment target

~20 participants

Started

June 2012

Primary completion

December 2026

Age range

10 Years – 60 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.